{"id":"NCT03703336","sponsor":"Center for Research and Production of Vaccines and Biologicals, Vietnam","briefTitle":"Phase III Study of Liquid Formulation of ROTAVIN","officialTitle":"A Phase III, Randomized, Partially Double- Blind, Active Control Study to Compare the Immunogenicity and Safety of a Liquid Formulation of ROTAVIN With the Currently Licensed Frozen Formulation of the Vaccine (ROTAVIN-M1), in Healthy Vietnamese Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-16","primaryCompletion":"2020-01-08","completion":"2020-01-08","firstPosted":"2018-10-11","resultsPosted":"2021-01-25","lastUpdate":"2021-01-25"},"enrollment":825,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Diarrhea","Diarrhea Rotavirus"],"interventions":[{"type":"BIOLOGICAL","name":"ROTAVIN (liquid formulation)","otherNames":[]},{"type":"BIOLOGICAL","name":"ROTAVIN-M1 (frozen formulation)","otherNames":[]}],"arms":[{"label":"ROTAVIN Liquid Formulation","type":"EXPERIMENTAL"},{"label":"ROTAVIN-M1 Frozen Formulation","type":"ACTIVE_COMPARATOR"}],"summary":"This study is conducted to demonstrate non-inferiority in the immunogenicity of the liquid formulation of ROTAVIN in comparison to currently licensed frozen formulation of the vaccine (ROTAVIN-M1), 28 days after the second vaccination when administered as two dose series starting at 2-3 months of age.\n\nThe study will also assess the reactogenicity of the vaccine 7 days after each vaccination and safety from first vaccination up to 4 weeks after the last vaccination.","primaryOutcome":{"measure":"Geometric Mean Concentration (GMC) of Serum Anti-rotavirus Immunoglobulin A (IgA) Antibodies 28 Days After Second Vaccination","timeFrame":"Day 85 (28 days after the second vaccination)","effectByArm":[{"arm":"ROTAVIN Liquid Formulation","deltaMin":48.25,"sd":null},{"arm":"ROTAVIN-M1 Frozen Formulation","deltaMin":35.04,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"60 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["Vietnam"]},"refs":{"pmids":["34218961"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":551},"commonTop":["Pyrexia","Upper respiratory tract infection","Cough","Nasopharyngitis","Bronchitis"]}}